110 related articles for article (PubMed ID: 38485610)
1. Exploring the ADAM12 Expression in Clear Cell Renal Cell Carcinoma: A Radiogenomic Analysis on CT Imaging.
Greco F; Panunzio A; Bernetti C; Tafuri A; Beomonte Zobel B; Mallio CA
Acad Radiol; 2024 Mar; ():. PubMed ID: 38485610
[TBL] [Abstract][Full Text] [Related]
2. CT-Based Radiogenomics of P4HA3 Expression in Clear Cell Renal Cell Carcinoma.
Greco F; Panunzio A; Tafuri A; Bernetti C; Pagliarulo V; Zobel BB; Scardapane A; Mallio CA
Acad Radiol; 2024 Mar; 31(3):902-908. PubMed ID: 37537130
[TBL] [Abstract][Full Text] [Related]
3. ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway.
Xu J; Wang Y; Jiang J; Yin C; Shi B
J Transl Med; 2023 Jan; 21(1):56. PubMed ID: 36717944
[TBL] [Abstract][Full Text] [Related]
4. ADAM metallopeptidase domain 12 overexpression correlates with prognosis and immune cell infiltration in clear cell renal cell carcinoma.
Gao J; Yang D; Xu H; Yang K; Ma J; Xia J; Pan X
Bioengineered; 2022 Feb; 13(2):2412-2429. PubMed ID: 35094638
[TBL] [Abstract][Full Text] [Related]
5. A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma.
Gao J; Ye F; Han F; Jiang H; Zhang J
Front Immunol; 2022; 13():956679. PubMed ID: 36177018
[TBL] [Abstract][Full Text] [Related]
6. Radiogenomic Features of GIMAP Family Genes in Clear Cell Renal Cell Carcinoma: An Observational Study on CT Images.
Greco F; Panunzio A; Tafuri A; Bernetti C; Pagliarulo V; Beomonte Zobel B; Scardapane A; Mallio CA
Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895181
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
8. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
9. Radiogenomics in renal cell carcinoma.
Alessandrino F; Shinagare AB; Bossé D; Choueiri TK; Krajewski KM
Abdom Radiol (NY); 2019 Jun; 44(6):1990-1998. PubMed ID: 29713740
[TBL] [Abstract][Full Text] [Related]
10.
Cheng X; Sun D; Li H; Zhang J; Luo Q; Jin X; Chen Y; Yuan Q; Wang B
Transl Androl Urol; 2023 Apr; 12(4):642-658. PubMed ID: 37181237
[TBL] [Abstract][Full Text] [Related]
11. High VSX1 expression promotes the aggressiveness of clear cell renal cell carcinoma by transcriptionally regulating FKBP10.
Ma W; Li X; Yang L; Pan J; Chen Y; Lu Y; Dong X; Li D; Gan W
J Transl Med; 2022 Dec; 20(1):554. PubMed ID: 36463181
[TBL] [Abstract][Full Text] [Related]
12. Semantic Computed Tomography Features for Predicting BRCA1-associated Protein 1 and/or Tumor Protein p53 Gene Mutation Status in Clear Cell Renal Cell Carcinoma.
Wu XH; Zhu JM; Lin BH; Qiu QR; Ruan ZT; Wei Y; Xue XY; Zheng QS; Chen SH; Xu N
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):666-675. PubMed ID: 36586494
[TBL] [Abstract][Full Text] [Related]
13.
Wang B; Liu B; Luo Q; Sun D; Li H; Zhang J; Jin X; Cheng X; Niu J; Yuan Q; Chen Y
Transl Cancer Res; 2022 Jul; 11(7):2321-2337. PubMed ID: 35966310
[TBL] [Abstract][Full Text] [Related]
14. LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma.
Peng Y; Greenland NY; Lang UE; Stohr BA
Pathol Res Pract; 2022 Apr; 232():153831. PubMed ID: 35287088
[TBL] [Abstract][Full Text] [Related]
15. Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma.
Wang C; Dong K; Wang Y; Peng G; Song X; Yu Y; Shen P; Cui X
BMC Cancer; 2021 Aug; 21(1):890. PubMed ID: 34348693
[TBL] [Abstract][Full Text] [Related]
16. [Expression and significance of fibroblast growth factor receptor 2 in clear cell renal cell carcinoma].
Cai TY; Zhu ZP; Xu CR; Ji X; Lv TD; Guo ZK; Lin J
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):628-635. PubMed ID: 35950384
[TBL] [Abstract][Full Text] [Related]
17. Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma.
Zeng H; Chen L; Wang M; Luo Y; Huang Y; Ma X
Aging (Albany NY); 2021 Mar; 13(7):9960-9975. PubMed ID: 33795526
[TBL] [Abstract][Full Text] [Related]
18. Expression of gasdermin D in clear cell renal cell carcinoma and its effect on its biological function.
Zhang J; Wang Y; Ma J; Aimudula A
Front Oncol; 2023; 13():1163714. PubMed ID: 37483501
[TBL] [Abstract][Full Text] [Related]
19. High Prognostic Value of
Gasparro D; Scarlattei M; Silini EM; Migliari S; Baldari G; Cervati V; Graziani T; Campanini N; Maestroni U; Ruffini L
Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835825
[TBL] [Abstract][Full Text] [Related]
20. Identification of adhesion-associated extracellular matrix component thrombospondin 3 as a prognostic signature for clear cell renal cell carcinoma.
Chen X; Lin J; Chen M; Chen Q; Cai Z; Tang A
Investig Clin Urol; 2022 Jan; 63(1):107-117. PubMed ID: 34983129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
